DUSA Pharmaceuticals, Inc. (DUSA) Tops Q4 EPS by 3c
Tweet
Share
E-mailGet Alerts DUSA Hot Sheet
Price: $55.57 -0.8%
Financial Fact:
INCOME (LOSS) FROM OPERATIONS: 273.34K
Today's EPS Names:
OCCI, ALZN, ASPU, More
Financial Fact:
INCOME (LOSS) FROM OPERATIONS: 273.34K
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
DUSA Pharmaceuticals, Inc. (NASDAQ: DUSA) reported Q4 EPS of $0.16, $0.03 better than the analyst estimate of $0.13. Revenue for the quarter came in at $15.3 million versus the consensus estimate of $13.84 million.
For earnings history and earnings-related data on DUSA Pharmaceuticals, Inc. (DUSA) click here.
For earnings history and earnings-related data on DUSA Pharmaceuticals, Inc. (DUSA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Stitch Fix (SFIX) Tops Q4 EPS by 4c; Offers Guidance
- Interactive Strength reports record Q2 results, raises Q3 guidance
- Unity Bancorp CEO to retire in 2027, president to take over
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
